Identification of drugs associated with reduced severity of COVID-19: A case-control study in a large population
View ORCID ProfileAriel Israel, View ORCID ProfileAlejandro A. Schäffer, View ORCID ProfileAssi Cicurel, Ilan Feldhamer, Ameer Tal, View ORCID ProfileKuoyuan Cheng, View ORCID ProfileSanju Sinha, Eyal Schiff, Gil Lavie, View ORCID ProfileEytan Ruppin
doi: https://doi.org/10.1101/2020.10.13.20211953
Ariel Israel
1Division of Planning and Strategy, Clalit Health Services, Tel Aviv 62098, Israel
M.D., Ph.D.Alejandro A. Schäffer
3Cancer Data Science Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA 20892
Ph.D.Assi Cicurel
1Division of Planning and Strategy, Clalit Health Services, Tel Aviv 62098, Israel
2Clalit Health Services, Southern District and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel
M.D., M.B.A.Ilan Feldhamer
1Division of Planning and Strategy, Clalit Health Services, Tel Aviv 62098, Israel
M.A.Ameer Tal
1Division of Planning and Strategy, Clalit Health Services, Tel Aviv 62098, Israel
M.Sc.Kuoyuan Cheng
3Cancer Data Science Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA 20892
M.S.Sanju Sinha
3Cancer Data Science Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA 20892
B.Tech.Eyal Schiff
4Sheba Medical Center, Tel-Aviv University, Ramat Gan 52621, Israel
MDGil Lavie
1Division of Planning and Strategy, Clalit Health Services, Tel Aviv 62098, Israel
5Ruth and Bruce Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Haifa 3109601, Israel
M.D., M.H.A., M.B.A.Eytan Ruppin
3Cancer Data Science Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA 20892
M.D., Ph.D.
Data Availability
This study is based on patients' clinical data and cannot be shared outside of Clalit Health Services
Posted March 24, 2021.
Identification of drugs associated with reduced severity of COVID-19: A case-control study in a large population
Ariel Israel, Alejandro A. Schäffer, Assi Cicurel, Ilan Feldhamer, Ameer Tal, Kuoyuan Cheng, Sanju Sinha, Eyal Schiff, Gil Lavie, Eytan Ruppin
medRxiv 2020.10.13.20211953; doi: https://doi.org/10.1101/2020.10.13.20211953
Identification of drugs associated with reduced severity of COVID-19: A case-control study in a large population
Ariel Israel, Alejandro A. Schäffer, Assi Cicurel, Ilan Feldhamer, Ameer Tal, Kuoyuan Cheng, Sanju Sinha, Eyal Schiff, Gil Lavie, Eytan Ruppin
medRxiv 2020.10.13.20211953; doi: https://doi.org/10.1101/2020.10.13.20211953
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)